Eastwood Bio-Medical Canada Inc EBM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CA$1.91
- Day Range
- CA$1.85–1.90
- 52-Week Range
- CA$0.49–2.06
- Bid/Ask
- CA$1.30 / CA$2.00
- Shares Outstanding
- 68.89M
- Market Cap
- CA$128.13M
- Volume/Avg
- 946 / 10,845
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 157.77
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.eleotin.ca
Valuation
|
Metric
|
EBM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 157.77 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
EBM
|
|---|---|
Quick Ratio | 0.05 |
Current Ratio | 0.05 |
Interest Coverage | — |
Quick Ratio
EBM
Profitability
|
Metric
|
EBM
|
|---|---|
Return on Assets (Normalized) | −95.57% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
EBM
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|P#z$n@ | LOCK|PPv? | $127B | |||
| Moderna Inc
MRNA
| LOCK|%V&<nJ | LOCK|^h | $87B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|k%ztQW | LOCK|>jt& | $81B | |||
| argenx SE ADR
ARGX
| LOCK|z@PD?s% | LOCK|?@Z | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|x!BcgcB | LOCK|t? | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|#hL<Pkh | LOCK|!MLj@ | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|mjwL<K>b | LOCK|bzK@ | $27B | |||
| Incyte Corp
INCY
| LOCK|@^K!$Z | LOCK|N@ | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|X%v#J?^ | LOCK|hdf | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Mf$vg@< | LOCK|%z | $14B |
United States